This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
BNO 株式概要
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers.
Bionomics Limited 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | AU$0.01 |
| 52週高値 | AU$0.074 |
| 52週安値 | AU$0.009 |
| ベータ | 2.13 |
| 11ヶ月の変化 | -16.67% |
| 3ヶ月変化 | -52.38% |
| 1年変化 | -81.13% |
| 33年間の変化 | -92.86% |
| 5年間の変化 | -98.10% |
| IPOからの変化 | -98.48% |
最新ニュース
Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14
Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30株主還元
| BNO | AU Biotechs | AU 市場 | |
|---|---|---|---|
| 7D | 0% | 1.2% | 0.5% |
| 1Y | -81.1% | 5.6% | 9.9% |
業界別リターン: BNO underperformed the Australian Biotechs industry which returned -9.1% over the past year.
リターン対市場: BNO underperformed the Australian Market which returned 1.8% over the past year.
価格変動
| BNO volatility | |
|---|---|
| BNO Average Weekly Movement | 24.4% |
| Biotechs Industry Average Movement | 11.0% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 15.9% |
| 10% least volatile stocks in AU Market | 3.2% |
安定した株価: BNO's share price has been volatile over the past 3 months.
時間の経過による変動: BNO's weekly volatility has increased from 18% to 24% over the past year.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1996 | n/a | Spyros Papapetropoulos | www.bionomics.com.au |
Bionomics Limited 基礎のまとめ
| BNO 基礎統計学 | |
|---|---|
| 時価総額 | AU$14.69m |
| 収益（TTM） | -AU$24.91m |
| 売上高(TTM) | AU$6.02m |
2.4x
P/Sレシオ-0.6x
PER（株価収益率BNO は割高か？
公正価値と評価分析を参照収益と収入
| BNO 損益計算書（TTM） | |
|---|---|
| 収益 | AU$6.02m |
| 売上原価 | AU$19.80m |
| 売上総利益 | -AU$13.79m |
| その他の費用 | AU$11.13m |
| 収益 | -AU$24.91m |
直近の収益報告
Dec 31, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -0.017 |
| グロス・マージン | -229.04% |
| 純利益率 | -413.94% |
| 有利子負債／自己資本比率 | 0% |
BNO の長期的なパフォーマンスは？
過去の実績と比較を見る